WO2001052817A3 - Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles - Google Patents

Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles Download PDF

Info

Publication number
WO2001052817A3
WO2001052817A3 PCT/US2001/002299 US0102299W WO0152817A3 WO 2001052817 A3 WO2001052817 A3 WO 2001052817A3 US 0102299 W US0102299 W US 0102299W WO 0152817 A3 WO0152817 A3 WO 0152817A3
Authority
WO
WIPO (PCT)
Prior art keywords
biologically relevant
cochleate
relevant molecules
delivering biologically
cochleates
Prior art date
Application number
PCT/US2001/002299
Other languages
English (en)
Other versions
WO2001052817A2 (fr
Inventor
Leila Zarif
Tuo Jin
Ignacio Segarra
Raphael J Mannino
Original Assignee
Biodelivery Sciences Inc
Univ New Jersey Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/001684 external-priority patent/WO2000042989A2/fr
Application filed by Biodelivery Sciences Inc, Univ New Jersey Med filed Critical Biodelivery Sciences Inc
Priority to JP2001552865A priority Critical patent/JP2003529557A/ja
Priority to EP01903273A priority patent/EP1259224A2/fr
Priority to AU31114/01A priority patent/AU3111401A/en
Priority to CA002397792A priority patent/CA2397792A1/fr
Publication of WO2001052817A2 publication Critical patent/WO2001052817A2/fr
Publication of WO2001052817A3 publication Critical patent/WO2001052817A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

L'invention concerne un procédé de production d'une structure cochléaire de petite taille à base de lipide. Les structures cochléaires sont obtenues à partir de liposomes qui sont mis en suspension dans une solution aqueuse polymère à deux phases, ce qui permet de séparer de manière différentielle les structures à base de molécules polaires par séparation de phases. La solution polymère à deux phases contenant des liposomes, traitée à l'aide de molécules chargées positivement telles que Ca?2+ ou Zn2+¿, forme un précipité de structures cochléaires présentant des dimensions de particules inférieures à un micron. Le procédé peut être utilisé pour produire des structures cochléaires contenant des molécules biologiquement utiles.
PCT/US2001/002299 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles WO2001052817A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2001552865A JP2003529557A (ja) 2000-01-24 2001-01-24 コクリエート製剤、その調製方法および生物学的関連分子投与のための用途
EP01903273A EP1259224A2 (fr) 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles
AU31114/01A AU3111401A (en) 2000-01-24 2001-01-24 New cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
CA002397792A CA2397792A1 (fr) 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US2000/001684 WO2000042989A2 (fr) 1999-01-22 2000-01-24 Nouvelles formulations de structures cochleaires isolees dans des hydrogels, procede de preparation et utilisation de celles-ci pour administrer des molecules biologiquement utiles
USPCT/US00/01684 2000-01-24
US09/613,840 US6592894B1 (en) 1999-01-22 2000-07-11 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
US09/613,840 2000-07-11

Publications (2)

Publication Number Publication Date
WO2001052817A2 WO2001052817A2 (fr) 2001-07-26
WO2001052817A3 true WO2001052817A3 (fr) 2002-02-21

Family

ID=26680118

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/002299 WO2001052817A2 (fr) 2000-01-24 2001-01-24 Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles

Country Status (5)

Country Link
EP (1) EP1259224A2 (fr)
JP (1) JP2003529557A (fr)
AU (1) AU3111401A (fr)
CA (1) CA2397792A1 (fr)
WO (1) WO2001052817A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219473A1 (en) * 2002-03-26 2003-11-27 Leila Zarif Cochleates made with purified soy phosphatidylserine
WO2004064805A1 (fr) * 2003-01-15 2004-08-05 Biodelivery Sciences International, Inc. Preparations cochleaires de nutriants fragiles
JP4789208B2 (ja) 2003-04-09 2011-10-12 バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド タンパク質発現に向けられた渦巻型組成物
US20050013854A1 (en) 2003-04-09 2005-01-20 Mannino Raphael J. Novel encochleation methods, cochleates and methods of use
US20070258926A1 (en) * 2003-10-15 2007-11-08 Ltt Bio-Pharma Co., Ltd. Composition containing retinoic acid nanoparticles coated with inorganic salt of polyvalent metal
JP4422681B2 (ja) * 2003-10-15 2010-02-24 株式会社ナノエッグ 多価金属無機塩被覆レチノイン酸ナノ粒子の製造方法および当該製造方法により得られたナノ粒子
US20080220028A1 (en) 2006-12-15 2008-09-11 National Research Council Of Canada Archaeal polar lipid aggregates for administration to animals
AU2012250568B2 (en) * 2011-05-05 2017-06-29 Matinas Biopharma Nanotechnologies, Inc. Cochleate compositions and methods of making and using same
JP6923206B2 (ja) * 2015-04-22 2021-08-18 マティナス バイオファーマ ナノテクノロジーズ，インコーポレーテッド マイコバクテリア感染症及び肺疾患を治療するための組成物及び方法
EP3310338A4 (fr) * 2015-06-18 2018-12-26 Matinas BioPharma Nanotechnologies, Inc. Compositions et procédés pour le traitement de maladies ou de troubles inflammatoires
CN114053417A (zh) * 2016-07-12 2022-02-18 马丁尼斯生物制药纳米技术公司 用于中枢神经系统递送和治疗隐球菌感染的脂质卷包封的抗真菌化合物
KR101989789B1 (ko) * 2017-11-30 2019-06-18 (주) 에이치엔에이파마켐 포스파티딜세린/음이온계면활성제/염화칼슘을 이용한 코킬레이트

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997030725A1 (fr) * 1996-02-22 1997-08-28 Raphael James Mannino Vecteurs d'apport de structures cochleaires
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
WO2000042989A2 (fr) * 1999-01-22 2000-07-27 Biodelivery Sciences, Inc. Nouvelles formulations de structures cochleaires isolees dans des hydrogels, procede de preparation et utilisation de celles-ci pour administrer des molecules biologiquement utiles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
WO1997030725A1 (fr) * 1996-02-22 1997-08-28 Raphael James Mannino Vecteurs d'apport de structures cochleaires
WO2000042989A2 (fr) * 1999-01-22 2000-07-27 Biodelivery Sciences, Inc. Nouvelles formulations de structures cochleaires isolees dans des hydrogels, procede de preparation et utilisation de celles-ci pour administrer des molecules biologiquement utiles

Also Published As

Publication number Publication date
CA2397792A1 (fr) 2001-07-26
JP2003529557A (ja) 2003-10-07
EP1259224A2 (fr) 2002-11-27
WO2001052817A2 (fr) 2001-07-26
AU3111401A (en) 2001-07-31

Similar Documents

Publication Publication Date Title
DK1143933T3 (da) Hidtil ukendte hydrogelisolerede cochleat-formuleringer, fremgangsmåde til fremstilling og deres anvendelse ved afgivelse af biologisk relevante molekyler
WO2001052817A3 (fr) Nouvelles formulations cochleaires, procede de preparation et utilisation de celles-ci dans l'administration de molecules biologiquement utiles
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
Evans et al. Thermodynamics of solution of nonpolar gases in a fused salt. Hydrophobic bonding behavior in a nonaqueous system
WO2002096457A3 (fr) Formulations liquides stable s
EP1266959A3 (fr) Anlage und verfahren zur gewinnen von zellen
ES8404690A1 (es) Procedimiento de preparacion de una mezcla pulverulenta de al menos un constituyente lipidico anfifilo y eventualmente de al menos un constituyente de caracter hidrofobo o parcialmente hidrofobo.
WO2003037835A3 (fr) Procede d'elimination d'impuretes polarisables contenues dans des hydrocarbures et melanges d'hydrocarbures
TW356476B (en) Scratch-resistant conductive coatings
WO1999000137A3 (fr) Induction d'un phenotype de cellules dendritiques myeloides activees
DK0710113T3 (da) Præparat til forbedring af blodforsyning indeholdende magnetisk hårde partikler
IL174206A0 (en) Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
WO2002018572A3 (fr) Peptides de penetration de membrane et utilisations associees
CA2243946A1 (fr) Eau electrolytique reductrice et procede de preparation de celle-ci
WO2000009086A3 (fr) Formulation protegee, dans un seul flacon, pour molecules d'acide nucleique, ses procedes de fabrication par melangeage en ligne, produits et procedes associes
WO2002008408A3 (fr) Systemes de vecteurs modulaires
ES2064048T3 (es) Inhibicion de incrustaciones.
IL145557A (en) Immunoabsorber for use in sepsis therapy
AU4402400A (en) Method for separating organic substances from an aqueous mixture
AU2003268890A1 (en) Cosmetic and dermatological agent containing magnetic particles, production thereof, and use of the same
ATE330474T1 (de) Antimikrobielles mittel
CN106179108B (zh) 磁响应型多相泡沫体系及其制备方法
WO2002094209A3 (fr) Cremes lipoproteiques contenant des filtres uv
Lakey et al. Conformational change on calcium binding by the lipopeptide antibiotic amphomycin. A CD and monolayer study
MD1951G2 (ro) Metodă de depistare a acidului hialuronic în preparatele biologice

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

WWE Wipo information: entry into national phase

Ref document number: 2397792

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 552865

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 31114/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001903273

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001903273

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001903273

Country of ref document: EP